Clover Health Investments (CLOV) Cash from Financing Activities (2019 - 2026)

Clover Health Investments has reported Cash from Financing Activities for 8 years, with the latest figure at -$7.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 75.23% year-over-year to -$7.9 million; the trailing twelve-month figure through Mar 2026 stood at -$29.5 million (up 35.5% YoY), and the FY2025 full-year result was -$53.4 million, down 207.49% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$7.9 million, up from -$8.6 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $458000.0 in Q2 2022, with the low at -$31.7 million in Q1 2025.
• Historically, Cash from Financing Activities has averaged -$5.2 million across 5 years, with a median of -$3.4 million in 2024.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 101.8% — and 2024, when it sank 2073.47%.
• Clover Health Investments' Cash from Financing Activities stood at $56000.0 in 2022, then sank by 1575.0% to -$826000.0 in 2023, then plunged by 643.46% to -$6.1 million in 2024, then sank by 40.16% to -$8.6 million in 2025, then grew by 8.64% to -$7.9 million in 2026.
• The last three Cash from Financing Activities figures came in at -$7.9 million (Q1 2026), -$8.6 million (Q4 2025), and -$5.3 million (Q3 2025), per Business Quant data.